CVKD Q1 2026 Earnings Narrowing Losses and Steady Progress in Clinical Pipeline HYNE Q1 2026 Earnings Narrowing Losses Amid Quiet Quarter NTGR Q1 2026 Earnings Strong EPS Surprise Amid Strategic Shift XORTX Therapeutics Q1 2024 Earnings Steep EPS Miss Highlights PreRevenue Biotech Hurdles PCRX Q1 2026 Earnings EPS Beats Estimates on Operational Strength VirTra Inc VTSI Q1 2026 Earnings NarrowerThanExpected Loss Fails to Lift Shares Okta Could Raise Fiscal 2027 Guidance Amid Improved Demand and Execution Barclays Suggests